Vaccination of Front-Line Workers with the AstraZeneca COVID-19 Vaccine: Benefits in the Face of Increased Risk for Prothrombotic Thrombocytopenia

Amin Adibi, Mohammad Mozafarihashjin, Mohsen Sadatsafavi
doi: https://doi.org/10.1101/2021.04.11.21255138

Article Information

doi 
https://doi.org/10.1101/2021.04.11.21255138
History 
  • April 16, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Amin Adibia,*,
  2. Mohammad Mozafarihashjinb,c and
  3. Mohsen Sadatsafavia
  1. aRespiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia
  2. bLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario
  3. cDepartment of Microbiology, Sinai Health System, Toronto, Ontario
  1. ↵*Corresponding author; email: amin.adibi{at}ubc.ca
Back to top
Posted April 16, 2021.
Download PDF
Data/Code
Email
Vaccination of Front-Line Workers with the AstraZeneca COVID-19 Vaccine: Benefits in the Face of Increased Risk for Prothrombotic Thrombocytopenia
Amin Adibi, Mohammad Mozafarihashjin, Mohsen Sadatsafavi
medRxiv 2021.04.11.21255138; doi: https://doi.org/10.1101/2021.04.11.21255138
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area